1. Home
  2. RVYL vs AIMD Comparison

RVYL vs AIMD Comparison

Compare RVYL & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryvyl Inc.

RVYL

Ryvyl Inc.

HOLD

Current Price

$5.56

Market Cap

9.3M

ML Signal

HOLD

AIMD

Ainos Inc.

HOLD

Current Price

$1.42

Market Cap

10.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVYL
AIMD
Founded
2007
1984
Country
United States
United States
Employees
N/A
44
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3M
10.5M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
RVYL
AIMD
Price
$5.56
$1.42
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
46.4K
18.1K
Earning Date
05-19-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
60.34
N/A
EPS
N/A
N/A
Revenue
$55,998,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$297.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$0.44
52 Week High
$8.55
$4.50

Technical Indicators

Market Signals
Indicator
RVYL
AIMD
Relative Strength Index (RSI) 49.95 47.98
Support Level $5.31 $1.33
Resistance Level $6.15 $1.69
Average True Range (ATR) 0.60 0.10
MACD 0.01 0.01
Stochastic Oscillator 60.37 37.92

Price Performance

Historical Comparison
RVYL
AIMD

About RVYL Ryvyl Inc.

Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.

About AIMD Ainos Inc.

Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.

Share on Social Networks: